• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续静脉注射吗啡治疗重度癌痛的安全性与有效性

Safety and efficacy of continuous intravenous morphine for severe cancer pain.

作者信息

Citron M L, Johnston-Early A, Fossieck B E, Krasnow S H, Franklin R, Spagnolo S V, Cohen M H

出版信息

Am J Med. 1984 Aug;77(2):199-204. doi: 10.1016/0002-9343(84)90691-0.

DOI:10.1016/0002-9343(84)90691-0
PMID:6205587
Abstract

To study the efficacy and safety of continuously administered intravenous morphine for cancer pain unrelieved by standard narcotic therapy, bolus intravenous injections of 2 to 5 mg of morphine were given every 10 minutes until pain relief was achieved. Within the next hour, continuous intravenous morphine infusion was begun with the hourly dose equal to the cumulative bolus dose. Respiratory rate, pulse, blood pressure, arterial blood gas values, mental status, and pain relief were recorded at baseline and during the study period. A reduction in arterial oxygen pressure (PaO2) and/or increase in arterial carbon dioxide pressure PaCO2 of more than 20 percent of baseline values occurred, during the first 24 hours of infusion, in a minority of patients. This did not require changes in hourly morphine dose. Despite subsequent increases in morphine dose, blood gas values tended to remain at or return toward baseline values. Severe toxicity occurred during one trial and was heralded by bradypnea and marked somnolence. Major pain relief was achieved in 11 of 15 trials. Therefore, continuous intravenous morphine is effective and safe therapy. Bradypnea associated with marked somnolence is a cause for dose reduction.

摘要

为研究持续静脉注射吗啡对标准麻醉治疗无法缓解的癌痛的疗效和安全性,每10分钟静脉推注2至5毫克吗啡,直至疼痛缓解。在接下来的一小时内,开始持续静脉输注吗啡,每小时剂量等于累积推注剂量。在基线和研究期间记录呼吸频率、脉搏、血压、动脉血气值、精神状态和疼痛缓解情况。在少数患者中,在输注的最初24小时内,动脉血氧分压(PaO2)降低和/或动脉血二氧化碳分压(PaCO2)升高超过基线值的20%。这并不需要改变每小时的吗啡剂量。尽管随后增加了吗啡剂量,但血气值往往保持在基线值或恢复到基线值。在一次试验中发生了严重毒性反应,表现为呼吸过缓和明显嗜睡。15次试验中有11次实现了主要的疼痛缓解。因此,持续静脉注射吗啡是一种有效且安全的治疗方法。伴有明显嗜睡的呼吸过缓是减少剂量的原因。

相似文献

1
Safety and efficacy of continuous intravenous morphine for severe cancer pain.持续静脉注射吗啡治疗重度癌痛的安全性与有效性
Am J Med. 1984 Aug;77(2):199-204. doi: 10.1016/0002-9343(84)90691-0.
2
Continuous intravenous infusion of morphine for severe dyspnea.
South Med J. 1991 Feb;84(2):229-34. doi: 10.1097/00007611-199102000-00019.
3
Intravenous morphine for rapid control of severe cancer pain.静脉注射吗啡用于快速控制重度癌痛。
Palliat Med. 2003 Apr;17(3):248-56. doi: 10.1191/0269216303pm695oa.
4
Continuous intravenous morphine infusions for terminal pain control: a retrospective review.持续静脉输注吗啡用于终末期疼痛控制:一项回顾性研究。
Drug Intell Clin Pharm. 1986 Dec;20(12):968-72. doi: 10.1177/106002808602001211.
5
Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion.
Cancer. 2002 Jul 1;95(1):203-8. doi: 10.1002/cncr.10636.
6
Clearance of continuous intravenous morphine for severe cancer pain.重度癌痛患者持续静脉输注吗啡的清除率
Drug Intell Clin Pharm. 1987 Dec;21(12):981-5. doi: 10.1177/106002808702101211.
7
The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer.持续静脉输注吗啡(CIVM)用于治疗晚期癌症所致疼痛和症状的疗效及副作用。
Am J Hosp Palliat Care. 2002 Sep-Oct;19(5):343-50. doi: 10.1177/104990910201900512.
8
A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain.一项关于连续静脉注射和皮下注射吗啡治疗慢性癌痛的前瞻性、患者自身交叉研究。
J Pain Symptom Manage. 1997 May;13(5):262-7. doi: 10.1016/s0885-3924(96)00329-6.
9
Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use.癌症疼痛的患者自控镇痛:住院和门诊使用的长期研究。
Cancer Invest. 1992;10(5):335-41. doi: 10.3109/07357909209024792.
10
Inpatient narcotic infusions for patients with cancer pain.癌症疼痛患者的住院麻醉剂输注
J Palliat Care. 1990 Summer;6(2):51-9.

引用本文的文献

1
Adverse Drug Reactions in Japanese Patients with End-Stage Heart Failure Receiving Continuous Morphine Infusion: A Single-Center Retrospective Cohort Study.日本终末期心力衰竭患者持续静脉输注吗啡时的药物不良反应:一项单中心回顾性队列研究。
Drugs Real World Outcomes. 2022 Mar;9(1):1-8. doi: 10.1007/s40801-021-00281-4. Epub 2021 Oct 6.
2
Continuous intravenous infusion of opioid analgesics for severe pain.持续静脉输注阿片类镇痛药治疗重度疼痛。
Can Fam Physician. 1989 Sep;35:1788-92.
3
Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.
镇静剂和镇痛药在治疗躁动危重症患者中的药代动力学和药效学
Clin Pharmacokinet. 1997 Dec;33(6):426-53. doi: 10.2165/00003088-199733060-00003.
4
Patient-controlled analgesia. Pharmacokinetic and therapeutic considerations.患者自控镇痛。药代动力学及治疗方面的考虑。
Clin Pharmacokinet. 1993 Feb;24(2):124-40. doi: 10.2165/00003088-199324020-00003.
5
The Infusaid pump in the management of intractable cancer pain.Infusaid泵在难治性癌痛管理中的应用
J Natl Med Assoc. 1987 Mar;79(3):305-11.
6
A practical approach to improving pain control in cancer patients.改善癌症患者疼痛控制的实用方法。
West J Med. 1987 May;146(5):580-4.
7
A computer-based system for controlling plasma opioid concentration according to patient need for analgesia.一种根据患者镇痛需求控制血浆阿片类药物浓度的计算机系统。
Clin Pharmacokinet. 1991 Apr;20(4):319-30. doi: 10.2165/00003088-199120040-00006.